Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Delft University of Technology (TU Delft)
- Maastricht University (UM)
- University of Exeter
- University of Oslo
- SciLifeLab
- University of East Anglia
- Technical University of Munich
- Hannover Medical School •
- Newcastle University
- University of Amsterdam (UvA)
- CNRS
- Linköping University
- University of Alabama at Birmingham
- Eindhoven University of Technology (TU/e)
- Forschungszentrum Jülich
- Harvard University
- NTNU - Norwegian University of Science and Technology
- NTNU Norwegian University of Science and Technology
- National University of Singapore
- Queensland University of Technology
- Sanquin Blood Supply Foundation (Sanquin)
- University of Bergen
- Utrecht University
- Adelaide University
- Amsterdam UMC
- Biofyzikální ústav Akademie věd ČR, v. v. i.
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- KNAW
- KU LEUVEN
- Leiden University
- Monash University
- Poznan University of Physical Education, POLAND
- REQUIMTE - Rede de Quimica e Tecnologia
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- UNIVERSITY OF HELSINKI
- University Medical Center Utrecht (UMC Utrecht)
- University of A Coruña
- University of Birmingham
- University of Copenhagen
- University of Florida
- University of Göttingen •
- VIB
- Vrije Universiteit Amsterdam (VU)
- Wageningen University & Research
- AITHYRA GmbH - Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences
- Bellvitge Biomedical Research Institute
- Biodiversity Research Institut-University of Barcelona (IRBio-UB)
- Center for Theoretical Physics PAS
- Centre for Genomic Regulation
- Dresden University of Technology •
- Duke University
- Empa
- European Synchrotron Radiation Facility
- Foundation for Research and Technology-Hellas
- Fundacio de Recerca Clinic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer
- Fundación IMDEA Nanociencia
- Fundación Investigación Biomédica del Hospital de la Princesa
- Hector Fellow Academy
- IDIVAL
- Imperial College London;
- Institutionen för mark och miljö
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- International PhD Programme (IPP) Mainz
- Karl Landsteiner University of Health Sciences
- LASE (University of Kent)
- Ludwig-Maximilians-Universität München •
- Max Planck Institute for Heart and Lung Research •
- Max Planck Institute for Marine Microbiology •
- Max Planck Institute for Plant Breeding Research •
- Max Planck Institute of Biochemistry •
- Max Planck Institute of Biochemistry, Martinsried
- Max Planck Institute of Immunobiology and Epigenetics •
- Max Planck Institute of Molecular Plant Physiology •
- Max Planck Institutes
- Medical University of Graz
- Montenegro Research Group – CIQUS
- National Institute of Research and Innovation
- Pennsylvania State University
- Radboud University Medical Center (Radboudumc)
- Swansea University;
- Swedish University of Agricultural Sciences
- TU Delft
- TUD Dresden University of Technology
- Technical University of Denmark (DTU)
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- The Ohio State University
- The University of Arizona
- The University of Chicago
- The University of Iowa
- The University of Manchester
- UNIVERSITE DE TECHNOLOGIE DE COMPIEGNE
- Umeå University
- University Medical Centre Groningen (UMCG)
- University of Antwerp
- University of Basel
- University of Bath;
- University of Bonn •
- University of Cambridge
- University of Cambridge;
- 90 more »
- « less
-
Field
-
) focuses on novel regenerative agents and biomaterials as well as cell transplants, artificial tissues, and cell-enhanced bioimplants. Doctoral students must hold a Master's degree or its equivalent in
-
of WP3: Leading the study of the degradation of Bulk Heterojunctions (BHJs) and evaluating the long-term stability of organic solar cells (OSCs) (Tasks 3.1 and 3.2 of the DoA). October 1, 2026 September 31
-
background and interests, you will contribute through complementary approaches such as: molecular and cell-based assays of influenza receptor binding; enzymatic modification or biosynthesis of glycans
-
partners responsible for BGC discovery, cell-free expression, analytical chemistry and bioprocess development. Participate in AIMARIA consortium meetings, scientific workshops and conferences. Publish
-
What you'll receive The CSIRO Industry PhD Program (iPhD) is a four-year research training program, focusing on applied research that benefits industry by solving real-world challenges. It aims
-
-Pathogen Interactions. The three-year programme, with English as the teaching language, plays a pivotal role in the training of young scientists in the field of infection biology. The programme's objective
-
three-year programme, with English as the teaching language, plays a pivotal role in the training of young scientists in the field of infection biology. The programme's objective is to investigate
-
-transmitted pathogenic viruses. The position is for four years of doctoral studies, including participation in research and postgraduate courses. The last day to apply is 13th July, 2026.Starting date is 28th
-
Max Planck Institute of Immunobiology and Epigenetics • | Freiburg im Breisgau, Baden W rttemberg | Germany | 2 months ago
everyday working language. Programme duration 8 semesters Beginning Winter semester Application periods The programme has one recruitment round per year, with a new call opening at the end of the year. More
-
these pathways in cells. The project will provide training in a wide-range of state-of-the-art biophysical, molecular biology and microbiological techniques, from characterizing different types of DNA/RNA